$UAMY
UNITED STATES ANTIMONY CORP Stock $uamy

$uamy Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000165495424004576 Filed on April 12, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$2.814M	$1.665M	$8.693M
YoY Change	12.39%	17.26%	-21.29%
Cost Of Revenue	$1.905M	$3.709M	$12.04M
YoY Change	-13.7%	117.05%	33.04%
Gross Profit	$908.6K	-$2.044M	-$3.345M
YoY Change	207.08%	607.53%	-267.56%
Gross Profit Margin	32.29%	-122.76%	-38.48%
Selling, General & Admin	$984.3K	$1.097M	$2.925M
YoY Change	29.0%	135.4%	102.78%
% of Gross Profit	108.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$114.5K	$245.1K	$959.4K
YoY Change	-52.52%	13.9%	5.52%
% of Gross Profit	12.6%
Operating Expenses	$1.122M	$1.460M	$3.724M
YoY Change	39.24%	159.73%	125.99%
Operating Profit	-$213.6K	-$3.505M	-$7.069M
YoY Change	-58.12%	311.73%	-2130.1%
Interest Expense	$151.9K	$155.2K	$688.7K
YoY Change	-6.36%	344.57%	-1826.52%
% of Operating Profit
Other Income/Expense, Net	$157.9K	$6.980K	$720.7K
YoY Change	-9.06%	-90.13%	428.31%
Pretax Income	-$55.70K	-$3.560M	-$6.348M
YoY Change	-83.45%	377.55%	-1527.45%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	$202.8K	-$3.562M	-$6.348M
YoY Change	-160.27%	360.57%	-1764.56%
Net Earnings / Revenue	7.21%	-213.91%	-73.03%
Basic Earnings Per Share	$108.4M		-$0.06
Diluted Earnings Per Share	$108.9M	-$0.03	-$0.06
COMMON SHARES
Basic Shares Outstanding	107.6M shares	107.6M shares
Diluted Shares Outstanding			107.6M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.41M	$11.97M	$11.97M
YoY Change	-10.99%	-38.03%	-38.03%
Cash & Equivalents	$12.39M	$11.90M	$11.90M
Short-Term Investments	$22.22K	$72.90K	$72.90K
Other Short-Term Assets	$342.0K	$92.37K	$92.37K
YoY Change	-9.47%	-32.87%	-32.87%
Inventory	$462.4K	$1.386M	$1.386M
Prepaid Expenses
Receivables	$1.394M	$625.3K	$625.3K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$14.61M	$14.08M	$14.08M
YoY Change	-18.75%	-34.88%	-34.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.799M	$13.45M	$13.45M
YoY Change	-40.06%	10.94%	10.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.519M	$509.2K	$564.3K
YoY Change	434.99%	-46.68%	-40.91%
Total Long-Term Assets	$14.32M	$14.02M	$14.02M
YoY Change	0.22%	7.15%	7.15%
TOTAL ASSETS
Total Short-Term Assets	$14.61M	$14.08M	$14.08M
Total Long-Term Assets	$14.32M	$14.02M	$14.02M
Total Assets	$28.93M	$28.09M	$28.10M
YoY Change	-10.35%	-19.04%	-19.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$544.1K	$456.9K	$456.9K
YoY Change	33.64%	-27.33%	-27.33%
Accrued Expenses	$157.0K	$133.8K	$258.7K
YoY Change	-30.07%	-51.17%	-5.64%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$130.0K	$28.44K	$28.44K
YoY Change	57.4%	-69.79%	-69.79%
Total Short-Term Liabilities	$1.252M	$897.5K	$897.5K
YoY Change	28.04%	-59.57%	-59.57%
LONG-TERM LIABILITIES
Long-Term Debt	$262.1K	$0.00	$0.00
YoY Change	43.19%	-100.0%	-100.0%
Other Long-Term Liabilities	$1.713M	$1.677M	$1.677M
YoY Change	347.87%	326.1%	326.1%
Total Long-Term Liabilities	$262.1K	$0.00	$1.677M
YoY Change	43.19%	-100.0%	174.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.252M	$897.5K	$897.5K
Total Long-Term Liabilities	$262.1K	$0.00	$1.677M
Total Liabilities	$3.227M	$2.574M	$2.574M
YoY Change	109.1%	-9.08%	-9.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.54M	-$39.42M
YoY Change	15.56%	19.2%
Common Stock	$1.084M	$1.076M
YoY Change	0.74%	1.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$0.00
YoY Change		-100.0%
Treasury Stock Shares
Shareholders Equity	$25.70M	$25.52M	$25.52M
YoY Change
Total Liabilities & Shareholders Equity	$28.93M	$28.09M	$28.10M
YoY Change	-10.35%	-19.04%	-19.04%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$202.8K	-$3.562M	-$6.348M
YoY Change	-160.27%	360.57%	-1764.56%
Depreciation, Depletion And Amortization	$114.5K	$245.1K	$959.4K
YoY Change	-52.52%	13.9%	5.52%
Cash From Operating Activities	$565.9K	-$932.1K	-$4.750M
YoY Change	-161.67%	242.45%	1805.5%
INVESTING ACTIVITIES
Capital Expenditures	$98.01K	$8.950K	$1.529M
YoY Change	-86.63%	-99.21%	-11.45%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$187.0K	$187.0K
YoY Change		-98.57%	-415.54%
Cash From Investing Activities	-$98.01K	$178.0K	-$1.342M
YoY Change	-86.63%	-98.5%	-24.86%
FINANCING ACTIVITIES
Cash Dividend Paid			$787.7K
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net			$283.6K
YoY Change			337.97%
Cash From Financing Activities	-17.80K	-213.5K	-$1.071M
YoY Change	-23.77%	-5.38%	300.14%
NET CHANGE
Cash From Operating Activities	565.9K	-932.1K	-$4.750M
Cash From Investing Activities	-98.01K	178.0K	-$1.342M
Cash From Financing Activities	-17.80K	-213.5K	-$1.071M
Net Change In Cash	450.1K	-967.6K	-$7.163M
YoY Change	-126.89%	-108.49%	211.08%
FREE CASH FLOW
Cash From Operating Activities	$565.9K	-$932.1K	-$4.750M
Capital Expenditures	$98.01K	$8.950K	$1.529M
Free Cash Flow	$467.9K	-$941.1K	-$6.279M
YoY Change	-128.35%	-33.09%	217.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11899574	usd
CY2023Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	72898	usd
CY2022Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	259857	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	625256	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	92369	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	14076206	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13454491	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	55061	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	509237	usd
CY2023Q4	us-gaap	Assets Assets	28094995	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	456935	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	133841	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	0	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	787730	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	28443	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	94150	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	897458	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2219870	usd
CY2023Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	1638027	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2574027	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	106373341	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1063732	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	784457	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	137599	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	21617359	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12128124	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	57288	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	897679	usd
CY2022Q4	us-gaap	Assets Assets	34700450	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	628803	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	201149	usd
CY2022Q4	uamy	Due To Related Party Current DueToRelatedPartyCurrent	72963	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	217855	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	332011	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2831195	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	64052630	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28094995	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34700450	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1386109	usd
CY2023Q4	uamy	Due To Related Party Current DueToRelatedPartyCurrent	124810	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	153429	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107647317	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1076472	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	63853836	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000101538
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107647317	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	106373341	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-08675
CY2023	dei	Entity Registrant Name EntityRegistrantName	UNITED STATES ANTIMONY CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MT
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-0305822
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	P.O. Box 643
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Thompson Falls
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MT
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	59873
CY2023	dei	City Area Code CityAreaCode	406
CY2023	dei	Local Phone Number LocalPhoneNumber	827-3523
CY2023	dei	Trading Symbol TradingSymbol	UAMY
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	30438620	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	107647317	shares
CY2023	dei	Auditor Firm AuditorFirmId	444
CY2023	dei	Auditor Name AuditorName	Assure CPA, LLC
CY2023	dei	Auditor Location AuditorLocation	Spokane, WA
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19060378	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1375068	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	435075	usd
CY2023Q4	uamy	Stock Payable To Director StockPayableToDirector	38542	usd
CY2022Q4	uamy	Stock Payable To Director StockPayableToDirector	61459	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	202980	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39418619	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33070332	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	25520968	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	31869255	usd
CY2023	us-gaap	Revenues Revenues	8693155	usd
CY2022	us-gaap	Revenues Revenues	11044707	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	12037939	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	9048517	usd
CY2023	us-gaap	Gross Profit GrossProfit	-3344784	usd
CY2022	us-gaap	Gross Profit GrossProfit	1996190	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1642269	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	658242	usd
CY2023	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	639172	usd
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	481106	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	643208	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	302901	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-217921	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	581647	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	205736	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	3724217	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1647985	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-7069001	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	348205	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	618762	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	103800	usd
CY2023	uamy	Change In Fair Value Of Investments Net ChangeInFairValueOfInvestmentsNet	0	usd
CY2022	uamy	Change In Fair Value Of Investments Net ChangeInFairValueOfInvestmentsNet	-37882	usd
CY2023	uamy	Income From Trademark And Licensing IncomeFromTrademarkAndLicensing	32007	usd
CY2022	uamy	Income From Trademark And Licensing IncomeFromTrademarkAndLicensing	70502	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	69945	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-39891	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	720714	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	96529	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6348287	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	444734	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16073	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6348287	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	428661	usd
CY2023	uamy	Preferred Dividends PreferredDividends	-7500	usd
CY2022	uamy	Preferred Dividends PreferredDividends	-47278	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6355787	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	381383	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	107551931	shares
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	106287359	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107551931	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106287359	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	32368803	usd
CY2022	uamy	Issuance Of Common Stock For Directors Fees Amount IssuanceOfCommonStockForDirectorsFeesAmount	62501	usd
CY2022	uamy	Series D Preferred Dividends Declared SeriesDPreferredDividendsDeclared	-787730	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	202980	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	428661	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	31869255	usd
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	0	usd
CY2023	uamy	Conversion Of Preferred Series D To Common Stock Amount ConversionOfPreferredSeriesDToCommonStockAmount	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6348287	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	25520968	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-6348287	usd
CY2022	us-gaap	Profit Loss ProfitLoss	428661	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	959445	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	909220	usd
CY2023	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	13471	usd
CY2022	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	17766	usd
CY2023	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	324984	usd
CY2022	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	0	usd
CY2023	uamy	Stock Payable To Directors StockPayableToDirectors	-22917	usd
CY2022	uamy	Stock Payable To Directors StockPayableToDirectors	61459	usd
CY2023	uamy	Loss On Disposal Of Property Plant Equipment LossOnDisposalOfPropertyPlantEquipment	217921	usd
CY2022	uamy	Loss On Disposal Of Property Plant Equipment LossOnDisposalOfPropertyPlantEquipment	0	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	2073404	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	277146	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	239772	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	59350	usd
CY2023	uamy	Reserve On Iva Receivable ReserveOnIvaReceivable	687534	usd
CY2022	uamy	Reserve On Iva Receivable ReserveOnIvaReceivable	0	usd
CY2023	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	59246	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-7500	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-647	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-80571	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	47507	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2084445	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-596794	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	45230	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-137599	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-299092	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-654958	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-171868	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-756949	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-67308	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-72636	usd
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	51847	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	21118	usd
CY2023	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	-281646	usd
CY2022	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	88833	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4750026	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-249277	usd
CY2023	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits	186959	usd
CY2022	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits	0	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	16184893	usd
CY2023	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	0	usd
CY2022	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	16125647	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1528672	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1726415	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1341713	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1785661	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	787730	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	283562	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	64745	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	202980	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1071292	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-267725	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7163031	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2302663	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19117666	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21420329	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11954635	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19117666	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	10521	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	15141	usd
CY2023	uamy	Equipment Purchased With Note Payable EquipmentPurchasedWithNotePayable	0	usd
CY2022	uamy	Equipment Purchased With Note Payable EquipmentPurchasedWithNotePayable	161600	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	62501	usd
CY2023	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	787730	usd
CY2023	uamy	Common Stock Buyback And Retirement CommonStockBuybackAndRetirement	202980	shares
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	16926	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 - NATURE OF OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">United States Antimony Corporation and its subsidiaries in the U.S. and Mexico (“USAC”, the “Company”, “Our”, “Us”, or “We”) sell processed antimony, zeolite, and precious metals products in the U.S. and Canada. The Company processes antimony ore primarily into antimony oxide, antimony metal, and antimony trisulfide. Our antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Our antimony metal is used in bearings, storage batteries, and ordnance. Our antimony trisulfide is used as a primer in ammunition. In its operations in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, and other miscellaneous applications. We recover precious metals, primarily gold and silver, at our plant in Montana from antimony concentrates.</p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting estimates include impairment of long-lived assets, antimony content of mineral resources, and asset retirement obligations. Actual results could differ from those estimates.</p>
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	55061	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	57288	usd
CY2023	uamy	Prepaidexpensesandotherlongtermassets Policy Textblock PrepaidexpensesandotherlongtermassetsPolicyTextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Prepaid expenses relate to goods or services that have been paid for but for which the good or service has not been received yet. These expenses are recorded as an asset in the Consolidated Balance Sheet and expensed in the Consolidated Statement of Operations as the asset's benefits are realized. Prepaid expenses are recorded as a current asset in the Consolidated Balance Sheet if the benefits will be realized within twelve months from the date of the Consolidated Balance Sheet or as a long-term asset if the benefits will be realized after twelve months from the date of the Consolidated Balance Sheet.</p>
CY2023	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	12346215	usd
CY2022	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	14038887	usd
CY2023	us-gaap	Revenues Revenues	8693155	usd
CY2022	us-gaap	Revenues Revenues	11044707	usd
CY2023	us-gaap	Revenues Revenues	8693155	usd
CY2022	us-gaap	Revenues Revenues	11044707	usd
CY2023	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	4037540	usd
CY2022	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	3746625	usd
CY2023	us-gaap	Premiums Percentage Assumed To Net PremiumsPercentageAssumedToNet	0.46	pure
CY2022	us-gaap	Premiums Percentage Assumed To Net PremiumsPercentageAssumedToNet	0.34	pure
CY2023	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	326496	usd
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	261707	usd
CY2023Q4	us-gaap	Financing Receivable Nonaccrual Percent Past Due1 FinancingReceivableNonaccrualPercentPastDue1	0.10	pure
CY2022Q4	uamy	Receivablesfromcustomers Net ReceivablesfromcustomersNet	188187	usd
CY2023Q4	uamy	Receivablesfromcustomers Net ReceivablesfromcustomersNet	396389	usd
CY2023Q4	srt	Financing Receivable Nonaccrual To Outstanding Percent FinancingReceivableNonaccrualToOutstandingPercent	0.63	pure
CY2022Q4	srt	Financing Receivable Nonaccrual To Outstanding Percent FinancingReceivableNonaccrualToOutstandingPercent	0.24	pure
CY2023Q4	us-gaap	Contract With Customer Receivable Allowance For Credit Loss ContractWithCustomerReceivableAllowanceForCreditLoss	625256	usd
CY2022Q4	us-gaap	Contract With Customer Receivable Allowance For Credit Loss ContractWithCustomerReceivableAllowanceForCreditLoss	784457	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	271212	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	31440	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1386109	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1375068	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	2073404	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	277146	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17755186	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	3143315	usd
CY2023Q4	us-gaap	Land Land	6179238	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	8951	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	27086690	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13632199	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13454491	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17195914	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2160805	usd
CY2022Q4	us-gaap	Land Land	5244177	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	450941	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25051837	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12923713	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12128124	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13454491	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12128124	usd
CY2023Q4	uamy	Assets Not Yet Placed In Service AssetsNotYetPlacedInService	289357	usd
CY2022Q4	uamy	Assets Not Yet Placed In Service AssetsNotYetPlacedInService	1117041	usd
CY2022Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	224511	usd
CY2021Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	191149	usd
CY2023	uamy	Revisions To Estimate Of Retirement Obligations RevisionsToEstimateOfRetirementObligations	1075061	usd
CY2022	uamy	Revisions To Estimate Of Retirement Obligations RevisionsToEstimateOfRetirementObligations	15596	usd
CY2023	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	13471	usd
CY2022	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	17766	usd
CY2023	us-gaap	Asset Retirement Obligation Period Increase Decrease AssetRetirementObligationPeriodIncreaseDecrease	324984	usd
CY2022	us-gaap	Asset Retirement Obligation Period Increase Decrease AssetRetirementObligationPeriodIncreaseDecrease	0	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	1638027	usd
CY2022Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	224511	usd
CY2023	uamy	Revisions To Estimate Of Retirement Obligations RevisionsToEstimateOfRetirementObligations	1075061	usd
CY2022	uamy	Revisions To Estimate Of Retirement Obligations RevisionsToEstimateOfRetirementObligations	15596	usd
CY2023	us-gaap	Asset Retirement Obligation Period Increase Decrease AssetRetirementObligationPeriodIncreaseDecrease	324984	usd
CY2023	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0665	pure
CY2022	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.06	pure
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	332011	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	28443	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	312005	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	28443	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	94150	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	0	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	217855	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	28443	usd
CY2023	uamy	Current Domestic Tax Expense Benefit CurrentDomesticTaxExpenseBenefit	0	usd
CY2022	uamy	Current Domestic Tax Expense Benefit CurrentDomesticTaxExpenseBenefit	16073	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16073	usd
CY2023	uamy	Deferred Domestic Income Tax Expense Benefit DeferredDomesticIncomeTaxExpenseBenefit	0	usd
CY2022	uamy	Deferred Domestic Income Tax Expense Benefit DeferredDomesticIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16073	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-397156	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	2729793	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-5951131	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2285059	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6348287	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	444734	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1333000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	93073	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-88000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	67000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-536000	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1692672	shares
CY2023Q1	uamy	Cash Paid To Shareholders CashPaidToShareholders	787730	usd
CY2023Q1	uamy	Description Of Returned Of Shares DescriptionOfReturnedOfShares	the Company returned to treasury and cancelled 418,696 of its common shares which were repurchased prior to December 31, 2022 for $202,980
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-136000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1008000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	4000	usd
CY2023	uamy	Income Tax Reconciliation Prior Year Tax Estimate To Actual Federal IncomeTaxReconciliationPriorYearTaxEstimateToActualFederal	-7000	usd
CY2022	uamy	Income Tax Reconciliation Prior Year Tax Estimate To Actual Federal IncomeTaxReconciliationPriorYearTaxEstimateToActualFederal	69000	usd
CY2023	uamy	Income Tax Reconciliation Prior Year Tax Estimate To Actual Foreign IncomeTaxReconciliationPriorYearTaxEstimateToActualForeign	136000	usd
CY2022	uamy	Income Tax Reconciliation Prior Year Tax Estimate To Actual Foreign IncomeTaxReconciliationPriorYearTaxEstimateToActualForeign	-32000	usd
CY2023	uamy	Impact On Change In State Tax Rate ImpactOnChangeInStateTaxRate	0	usd
CY2022	uamy	Impact On Change In State Tax Rate ImpactOnChangeInStateTaxRate	7000	usd
CY2023	uamy	Income Tax Reconciliation Change In Foreign Exchange Rate IncomeTaxReconciliationChangeInForeignExchangeRate	-275000	usd
CY2022	uamy	Income Tax Reconciliation Change In Foreign Exchange Rate IncomeTaxReconciliationChangeInForeignExchangeRate	-83000	usd
CY2023	uamy	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederal	170000	usd
CY2022	uamy	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederal	-358000	usd
CY2023	uamy	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance Foreign IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowanceForeign	925000	usd
CY2022	uamy	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance Foreign IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowanceForeign	385000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16073	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	646000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	307000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	2883000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	1958000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	64000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	7000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3598000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2272000	usd
CY2023Q4	uamy	Deferred Tax Assets Valuation Allowance Current Federal DeferredTaxAssetsValuationAllowanceCurrentFederal	228000	usd
CY2022Q4	uamy	Deferred Tax Assets Valuation Allowance Current Federal DeferredTaxAssetsValuationAllowanceCurrentFederal	58000	usd
CY2023Q4	uamy	Deferred Tax Assets Valuation Allowance Current Foreign DeferredTaxAssetsValuationAllowanceCurrentForeign	2883000	usd
CY2022Q4	uamy	Deferred Tax Assets Valuation Allowance Current Foreign DeferredTaxAssetsValuationAllowanceCurrentForeign	1958000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	487000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	256000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	487000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	245000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-11000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	487000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	256000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1660000	usd
CY2023	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	1.61 million of which will never expire but is limited to offsetting up to 80% of taxable income in any future year, and $0.05 million of which will expire at the end of 2037 but is not limited regarding offsetting taxable income in future years
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	153429	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	435075	usd
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132980	shares
CY2022Q3	uamy	Common Stock Shares Issued Ca CommonStockSharesIssuedCA	62501	usd
CY2023	uamy	Equityincentiveplan Textblock EquityincentiveplanTextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 12 – 2023 Equity Incentive Plan</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2023, the shareholders of the Company approved United States Antimony Corporation’s 2023 Equity Incentive Plan (“the Plan”). The Plan provides for the grant of incentive stock options and non-qualified stock options to purchase shares of our common stock and other types of awards. The general purpose of the Equity Incentive Plan is to provide a means whereby eligible employees, officers, non-employee directors and other individual service providers develop a sense of proprietorship and personal involvement in our development and financial success, and to encourage them to devote their best efforts to our business, thereby advancing our interests and the interests of our shareholders. By means of the Equity Incentive Plan, we seek to retain the services of such eligible persons and to provide incentives for such persons to exert maximum efforts for our success and the success of our subsidiaries. The maximum number of shares of common stock available for issuance in connection with options and other awards granted under the Equity Incentive Plan is 8,700,000. At December 31, 2023, no shares had been issued under the Plan.</p>
CY2023Q4	uamy	Maximum Number Of Shares Of Common Stock MaximumNumberOfSharesOfCommonStock	8700000	shares
CY2023Q4	us-gaap	Assets Assets	28094995	usd
CY2022Q4	us-gaap	Assets Assets	34700450	usd
CY2023	uamy	Capital Expenditure CapitalExpenditure	1528672	usd
CY2022	uamy	Capital Expenditure CapitalExpenditure	1888015	usd
CY2023	us-gaap	Revenues Revenues	8693155	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	959445	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-7069001	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	720714	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6348287	usd
CY2022	us-gaap	Revenues Revenues	11044707	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	909220	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	348205	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	96529	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16073	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	428661	usd

Files In Submission

Name	View Source	Status
0001654954-24-004576-index-headers.html	Edgar Link	pending
0001654954-24-004576-index.html	Edgar Link	pending
0001654954-24-004576.txt	Edgar Link	pending
0001654954-24-004576-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
uamy-20231231.xsd	Edgar Link	pending
uamy_10k.htm	Edgar Link	pending
uamy_10kimg13.jpg	Edgar Link	pending
uamy_10kimg14.jpg	Edgar Link	pending
uamy_10kimg15.jpg	Edgar Link	pending
uamy_10kimg16.jpg	Edgar Link	pending
uamy_10kimg17.jpg	Edgar Link	pending
uamy_10kimg18.jpg	Edgar Link	pending
uamy_10kimg19.jpg	Edgar Link	pending
uamy_10kimg20.jpg	Edgar Link	pending
uamy_10kimg21.jpg	Edgar Link	pending
uamy_10kimg22.jpg	Edgar Link	pending
uamy_10kimg23.jpg	Edgar Link	pending
uamy_10kimg24.jpg	Edgar Link	pending
uamy_ex101.htm	Edgar Link	pending
uamy_ex211.htm	Edgar Link	pending
uamy_ex311a.htm	Edgar Link	pending
uamy_ex311b.htm	Edgar Link	pending
uamy_ex312.htm	Edgar Link	pending
uamy_ex321.htm	Edgar Link	pending
uamy_ex41.htm	Edgar Link	pending
uamy_ex95.htm	Edgar Link	pending
uamy-20231231_lab.xml	Edgar Link	unprocessable
uamy-20231231_pre.xml	Edgar Link	unprocessable
uamy-20231231_def.xml	Edgar Link	unprocessable
uamy_10k_htm.xml	Edgar Link	completed
uamy_ex97.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
uamy-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UAMY
UNITED STATES ANTIMONY CORP Stock $uamy

2024 Q2 Form 10-K Financial Statement

#000165495424004576 Filed on April 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UAMY UNITED STATES ANTIMONY CORP Stock $uamy

2024 Q2 Form 10-K Financial Statement

#000165495424004576 Filed on April 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UAMY
UNITED STATES ANTIMONY CORP Stock $uamy